Filtrar por Last updated date SelectDespués deAntes deFrom - To Fecha Fecha de final Esta semana Este mes la semana pasada El mes pasado Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Deje este campo en blanco Filter Resultados (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Deje este campo en blanco Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2021 11 Junio 2021 News Human COVID-19 Pharmacovigilance Referrals COVID-19 vaccines: update on ongoing evaluation of myocarditis and pericarditis 11 Junio 2021 News Human COVID-19 Vaccines Vaxzevria: EMA advises against use in people with history of capillary leak syndrome 11 Junio 2021 News Human COVID-19 Vaccines International regulators and WHO address need to boost COVID-19 vaccine confidence 11 Junio 2021 News Human COVID-19 Vaccines EMA evaluating the use of COVID-19 Vaccine Moderna in young people aged 12 to 17 8 Junio 2021 News Human COVID-19 Vaccines EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome 7 Junio 2021 News Human COVID-19 Vaccines Advancing international collaboration on COVID-19 real-world evidence and observational studies 4 Junio 2021 News Human COVID-19 Medicines Vaccines EU regulators develop recommendations to forecast demand of medicines 3 Junio 2021 News Human COVID-19 Medicines Additional manufacturing capacity for BioNTech/Pfizer’s COVID-19 vaccine 1 Junio 2021 News Human COVID-19 Vaccines EMA and EUnetHTA take stock of their cooperation 1 Junio 2021 News Human Corporate 1 … 59 60 61 62 63 Page 63 of 380 64 65 66 67 … 380
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2021 11 Junio 2021 News Human COVID-19 Pharmacovigilance Referrals
COVID-19 vaccines: update on ongoing evaluation of myocarditis and pericarditis 11 Junio 2021 News Human COVID-19 Vaccines
Vaxzevria: EMA advises against use in people with history of capillary leak syndrome 11 Junio 2021 News Human COVID-19 Vaccines
International regulators and WHO address need to boost COVID-19 vaccine confidence 11 Junio 2021 News Human COVID-19 Vaccines
EMA evaluating the use of COVID-19 Vaccine Moderna in young people aged 12 to 17 8 Junio 2021 News Human COVID-19 Vaccines
EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome 7 Junio 2021 News Human COVID-19 Vaccines
Advancing international collaboration on COVID-19 real-world evidence and observational studies 4 Junio 2021 News Human COVID-19 Medicines Vaccines
EU regulators develop recommendations to forecast demand of medicines 3 Junio 2021 News Human COVID-19 Medicines
Additional manufacturing capacity for BioNTech/Pfizer’s COVID-19 vaccine 1 Junio 2021 News Human COVID-19 Vaccines